NCT07333846

Brief Summary

In children undergoing surgery, a venous access line almost always has to be placed. Through this line, medications and fluids can be administered during anesthesia or later during the hospital stay. In young children, it is often difficult to find a suitable vein. This can lead to multiple puncture attempts and may be a traumatic experience for both children and their parents. With ultrasound, however, in such difficult cases a specific vein on the forearm (the "cephalic vein") can usually be visualized and cannulated. Mostly, this vein is not visible to the naked eye. In our research project, we aim to determine whether it is possible to identify a simple and reliable anatomical orientation aid ("landmark") on the forearm that enables parents to place a topical anesthetic EMLA patch precisely at the correct location where the vein can subsequently be found using ultrasound. In this way, we want to assess whether this method simplifies the preparation for venipuncture and thereby increases the success rate. The examination is carried out during the routine preparation for anesthesia. In a first step, the course of the vein is identified by ultrasound, marked on the skin in a controlled manner, and photographic documentation of the forearm region is created. From this, a visual orientation guide describing the landmark is developed. In a second step, parents and staff of the anesthesia department mark the defined landmark using this visual orientation guide. Ultrasound is then used again to verify whether the vein is located at the marked site. No additional needle puncture is performed and no additional blood sample is taken.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
13mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jan 2026May 2027

First Submitted

Initial submission to the registry

December 31, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

January 6, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

December 31, 2025

Last Update Submit

January 27, 2026

Conditions

Keywords

landmarkperipheral venous accesscephalic veinvena cephalicaultrasound-guided venipunctureultrasound-guided placement intravenous line

Outcome Measures

Primary Outcomes (1)

  • Hit rate of cephalic vein within the marked and EMLA-covered area

    Proportion of cases where the cephalic vein is found within the user-marked area (staff or parent) and covered by the EMLA patch. (binary: yes/no). All outcome measures are assessed by ultrasound under general anesthesia.

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

Secondary Outcomes (6)

  • Distance (mm)

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

  • Vessel diameter (mm)

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

  • Vessel depth (mm)

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

  • Proximal course of the vein

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

  • Correlation of venous anatomy and patient characteristics

    Baseline (one ultrasound-examination after induction of anesthesia for planned surgery)

  • +1 more secondary outcomes

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children under 6 years of age scheduled for elective surgery under general anaesthesia at a single tertiary paediatric centre in Switzerland. Participants are recruited consecutively from the preoperative surgical list; parent/guardian consent is obtained. Setting: Department of Anaesthesiology, University Children's Hospital, Zurich, Switzerland.

You may qualify if:

  • Children under the age of 6 years
  • Scheduled elective procedure under general anesthesia
  • Admission via the surgical day clinic
  • Written informed consent by the parents (and by the child if capable of judgment)

You may not qualify if:

  • pre-existing intravenous access at the investigation site
  • Skin conditions or infections at the forearm site
  • Known allergy to EMLA or any of its components

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Childrens Hospital, Department of Anaesthesia and Children's Research Centre

Zurich, Canton of Zurich, 8032, Switzerland

RECRUITING

Study Officials

  • Alexander R Schmidt, MD

    University Children's Hospital, Zurich

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Vice Chief Department of Pediatric Anesthesia & Program Director for Research and Education, University Children's Hospital Zurich

Study Record Dates

First Submitted

December 31, 2025

First Posted

January 12, 2026

Study Start

January 6, 2026

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2027

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. De-identified data may be transmitted to the journal/publisher to meet publication requirements. Any further use of participant-level data outside this study is excluded by protocol and consent. Aggregate results and analysis methods will be available in publications

Locations